Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 d
Antidiarrheals for IBS-D, such as loperamide, which slow intestinal transit and reduce stool frequency
Clinical trial data show that headaches occur in patients receiving semaglutide, though the exact incidence varies by product and dose
Gamma-glutamyl transferase (GGT) processes glutathione (GSH), a key antioxidant, and detects inflammation and disease
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist Tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial